Medicenna Therapeutics Corp. (TSX:MDNA)
0.820
-0.020 (-2.38%)
At close: Mar 6, 2026
Medicenna Therapeutics Employees
Medicenna Therapeutics had 18 employees as of March 31, 2025. The number of employees increased by 2 or 12.50% compared to the previous year.
Employees
18
Change (1Y)
2
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-721.56K CAD
Market Cap
68.40M
Employees Chart
Medicenna Therapeutics News
- 17 days ago - Medicenna Therapeutics Announces Participation in Upcoming Conferences - GlobeNewsWire
- 18 days ago - Medicenna To Present Updated Bizaxofusp Data At 7th Annual Glioblastoma Development Summit - Nasdaq
- 22 days ago - Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 22 days ago - Medicenna Announces Changes to Board Composition - GlobeNewsWire
- 7 weeks ago - Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook - GlobeNewsWire
- 3 months ago - Medicenna Therapeutics Corp. (MDNA:CA) Discusses New Clinical Data From ABILITY-1 Study Evaluating MDNA11 in Cancer Immunotherapy Transcript - Seeking Alpha
- 3 months ago - Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors - GlobeNewsWire
- 3 months ago - Medicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data - GlobeNewsWire